VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald

VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald

Dow JonesMar 27 22:05

EF Hutton Maintains Buy on VolitionRX, Maintains $4.5 Price Target

EF Hutton analyst Tim Moore maintains VolitionRX with a Buy and maintains $4.5 price target.

Analyst UpgradesMar 27 21:43

VolitionRX Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 500.56% EF Hutton $4.5 → $4.5 Maintains Buy 01/02/2024 500.56% EF Hutton $4.5 → $4.5 Reiterates

BenzingaMar 27 21:37

Earnings Call Summary | VolitionRX(VNRX.US) Q4 2023 Earnings Conference

The following is a summary of the VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript:Financial Performance:VolitionRx recorded revenue of $775,000 for the full year 2023, a significantly highe

Futu NewsMar 27 01:12 · Conference Call

VolitionRX Reports FY Results

Seeking AlphaMar 26 13:52

VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate

VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 15.38 percent increase over losses of $(0.13) per share from the same period l

BenzingaMar 26 04:28